A recent retrospective cross-sectional observational study concluded that the Medios AI system, in conjunction with the Remidio smartphone-based fundus camera, has strong potential to ...
Management of geographic atrophy (GA) has changed with the introduction of retinal therapies aimed at slowing disease ...
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious adverse events reported across the Phase 1 and Phase 2 ...
This approach helps distinguish diseases associated with macular atrophy. The numbers are small, they noted, but an incorrect diagnosis can lead to inappropriate treatment. In their conclusion, the ...
Accurate diagnosis of retinal diseases is vital for effective treatment, especially with new therapies for GA and IRDs. A retrospective study found a 1.9% misdiagnosis rate of GA without drusen, ...
Mary is the bedrock of her family. “She’s the one we all go to,” says her son Eric. “She’s selfless, extremely sweet, very personable—but she can also be very feisty.” So when she returned from an eye ...
While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) focused on one condition or the other, retina specialists commonly encounter ...
Age-related retinal pigment epithelium disease is likely a “distinct clinical entity," with diffuse RPE changes, but no extracellular debris — a unique difference from AMD. A novel course for ...
Abstract: Pathological Myopia (PM) progresses through distinct stages—Tessellated Fundus, Choroidal Atrophy, and Patchy Atrophy. The limited availability of annotated datasets poses challenges for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results